BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rah B, Rather RA, Bhat GR, Baba AB, Mushtaq I, Farooq M, Yousuf T, Dar SB, Parveen S, Hassan R, Mohammad F, Qassim I, Bhat A, Ali S, Zargar MH, Afroze D. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. Front Pharmacol 2022;13:821344. [DOI: 10.3389/fphar.2022.821344] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Mascarenhas J. Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia. Expert Rev Hematol 2022. [PMID: 35983661 DOI: 10.1080/17474086.2022.2112565] [Reference Citation Analysis]
2 Park SD, Saunders AS, Reidy MA, Bender DE, Clifton S, Morris KT. A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer. Front Oncol 2022;12:932608. [DOI: 10.3389/fonc.2022.932608] [Reference Citation Analysis]
3 Atrisco-Morales J, Ramírez M, Castañón-Sánchez CA, Román-Román A, Román-Fernández IV, Martínez-Carrillo DN, García-Arellano S, Muñoz-Valle JF, Rodríguez-Ruiz HA, Fernández-Tilapa G. In Peripheral Blood Mononuclear Cells Helicobacter pylori Induces the Secretion of Soluble and Exosomal Cytokines Related to Carcinogenesis. Int J Mol Sci 2022;23:8801. [PMID: 35955936 DOI: 10.3390/ijms23158801] [Reference Citation Analysis]
4 Xing J, Jia Z, Li Y, Han Y. Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma. Front Oncol 2022;12:939385. [DOI: 10.3389/fonc.2022.939385] [Reference Citation Analysis]
5 Roskoski R Jr. Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders. Pharmacol Res 2022;183:106362. [PMID: 35878738 DOI: 10.1016/j.phrs.2022.106362] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]